INvestigational Study Into Transplantation of the Uterus
NCT ID: NCT04244409
Last Updated: 2020-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10 participants
OBSERVATIONAL
2019-02-18
2024-02-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transplantation of Uterus for Uterine infertiLIty From Living Donor or Deceased Donor
NCT05726305
Uterus Transplantation Procedure From a Live Donor
NCT04314869
Uterine Transposition: Feasibility Study
NCT03040921
Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH)
NCT03689842
Uterus Transplantation From Live Donors and From Deceased Donors - Clinical Study
NCT03277430
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age - 24-38 (or 40 if eggs frozen \<38)
3. AUFI
1. Normal length vagina
2. No renal pathology
4. BMI \<30kg/m2
5. ASA grade I
6. Meet psychological criteria
7. Meet HFEA criteria for IVF
8. Eligible for NHS treatment
9. Speak fluent English
Exclusion Criteria
2. Previous multiple/significant surgeries
3. Severe endometriosis
4. Cancer patients \<5 years in remission
5. Previous living childbirth, adopted child or child born through surrogacy
6. HIV or Hepatitis B / C positive
7. Skin or intestinal neovagina
24 Years
38 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oxford University Hospitals NHS Trust
OTHER
Imperial College Healthcare NHS Trust
OTHER
Womb Transplant UK
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ben Jones
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hammersmith Hospital, Imperial College NHS Trust
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WombTransplantUK
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.